Overview Healthcare data science jobs combine technical expertise with meaningful, real-world impact.Roles such as Data Engineer or Operations Analyst emphasize ...

Healthcare providers receive data from many disparate sources: hospitals, doctors’ offices, labs and lab machines, medical devices, pharmacies, and more. Investment in the correct infrastructure to ...

Clinical decision-making, hospital management, and patient care have all changed as a result of healthcare technology. Nurses have historically been thought of as providing bedside care, but they are ...

The promise and pursuit of artificial intelligence (AI) are undeniable. AI is reshaping how organizations interact with customers, streamline operations, manage risk, and uncover insights that were ...

Pure Storage’s recent launch of its Enterprise Data Cloud reignited debate around storage and data management. Pure claims its EDC addresses the management of growing volumes of data in a complex ...

IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Under the terms of the long-term agreement, customers can use ...

Once a promising but mostly supportive tool, artificial intelligence now stands at the center of how businesses manage and interpret customer data. Its capabilities are reshaping industries, enabling ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Healthcare organizations have long grappled with the complex challenge of managing provider ...

Myelofibrosis (MF) is a complex and clinically heterogeneous myeloproliferative neoplasm, presenting significant challenges for patient care and clinical decision making. Although global guidelines ...

• In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer (“mCRPC”),the six-month radiographic ...